The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex complicated chemical process. Initial routes focused on amino acid chain fragment coupling, utilizing solid-phase production methodologies to build the long peptide sequence. Subsequent investigation has explored alternative approaches,… Read More